Menu

1.800.860.4519

Sign In Get Started

No logo
A2A Oncology

Corporation

Chappaqua, New York HQ

Member since
2016
About
A2A is developing new drug candidates (NDC) for Lukemia, Pancreatic and Lung cancer. The NDCs are the product of sophisticated computer algorithms designed to optimize efficacy and safety across 10s of millions of potential molecules. Our objective is to prove that the NDCs are better than existing…
Team (1)
Sectors A2A Oncology serves:
Life Sciences

Join Axial's Private M&A Platform

A2A Oncology connects with qualified M&A advisors through the Axial Platform.

Looking for Buyers?

Reach this investor and hundreds more on Axial. No cost to advisors.

Join as Advisor

Selling Your Company?

Find the perfect advisor to help you sell your business.

Join as Owner

Double opt-in matching process ensures qualified connections

Member since
2016
Team (1)
Template
Join as Advisor Join as Owner